NCT04294160 2025-12-24A Study of Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal CancerNovartisPhase 1 Terminated122 enrolled
NCT03317119 2024-04-08Trametinib and Trifluridine and Tipiracil Hydrochloride in Treating Patients With Colon or Rectal Cancer That is Advanced, Metastatic, or Cannot Be Removed by SurgeryCity of Hope Medical CenterPhase 1 Completed26 enrolled
NCT04303403 2023-10-11Study of Trametinib and Ruxolitinib in Colorectal Cancer and Pancreatic AdenocarcinomaNational Cancer Centre, SingaporePhase 1 Unknown48 enrolled
NCT02900664 2022-03-29A Study of PDR001 in Combination With CJM112, EGF816, IlarisĀ® (Canakinumab) or MekinistĀ® (Trametinib)NovartisPhase 1 Completed283 enrolled
NCT02703571 2020-12-21Study of Safety and Efficacy of Ribociclib and Trametinib in Patients With Metastatic or Advanced Solid TumorsNovartisPhase 1 Terminated95 enrolled
NCT02538627 2017-09-05Phase 1 Combination Study of MM-151 With MM-121, MM-141, or TrametinibMerrimack PharmaceuticalsPhase 1 Terminated5 enrolled